You are here: Home / About NORD / How NORD is Funded / Corporate/ Foundation Supporters

Corporate/ Foundation Supporters

The National Organization for Rare Disorders (NORD) is grateful to its corporate and foundation supporters for their generosity. Through their contributions,* NORD is able to continue its important work. We extend our deepest thanks to all our benefactors.


2011


Sponsors

Sponsors have contributed $25,000 and above

  • Acorda Therapeutics, Inc.
  • Alexion Pharmaceuticals, Inc.
  • Allergan, Inc.
  • Allos Therapeutics Inc.
  • Aton Pharma, Inc.
  • Bausch and Lomb
  • Bayer HealthCare LLC
  • Biogen
  • BioMarin Pharmaceutical Inc.
  • Celgene Corporation
  • CSL Behring
  • Drug Information Association (DIA)
  • Elan (Azur)
  • Enobia Pharma Inc
  • Genzyme Corporation
  • GlaxoSmithKline RareDiseases
  • Healthwise, Incorporated
  • Lundbeck, Inc.
  • Marathon Pharmaceuticals, LLC
  • Medtronic Foundation
  • Medtronic, Inc.
  • Novartis Oncology
  • NPS Pharmaceuticals
  • Orphan Europe
  • Pfizer, Inc.
  • PMP Research Foundation
  • PTC Therapeutics, Inc.
  • Questcor Pharmaceuticals, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Shire Human Genetic Therapies
  • Sigma-Tau Pharmaceuticals, Inc.
  • Talecris Biotherapeutics
  • Tarlov Cyst Disease Foundation
  • Tev-Tropic
  • The Agnes Varis Charitable Trust
  • ViroPharma Inc.

Benefactors

Benefactors have contributed between $10,000 and $25,000

  • Actelion Pharmaceuticals, US, Inc.
  • Amicus Therapeutics
  • Baxter BioScience
  • Cephalon Inc.
  • Eli Lilly and Company
  • IDIS
  • InterMune, Inc.
  • Johnson & Johnson
  • Mark Krueger & Associates, Inc.
  • Medunik Canada.
  • Onyx Pharmaceuticals
  • Purdue Pharma LP
  • QLT, Inc.
  • QOL
  • Rare Disease Therapeutics, Inc.
  • United Therapeutics Corporation
  • Ziopharm Oncology, Inc.

Supporters

Supporters have contributed between $5,000 and $10,000

  • Accredo Health, Inc.
  • Aegerion Pharmaceuticals
  • Catt Family Foundation
  • Compass Healthcare Marketers
  • Hyperion Therapeutics
  • IKARIA
  • Incyte Corporation
  • Medicis Global Services Corporation
  • Milennium: The Takeda Oncology Company
  • Orphan Therapeutics LLC
  • Raptor Pharmaceutical Corporation
  • Simpson Healthcare, Inc.
  • Siren Interactive
  • Swedish Orphan Biovitrum AB
  • Synageva BioPharma
  • Upsher-Smith Laboratories, Inc.
  • Watson Laboratories, Inc.
  • William & Georgia Akers Private Foundation

Patrons

Patrons have contributed between $2,500 and $5,000

  • Accentia Biopharmaceuticals, Inc
  • Adolph & Ruth Schnurmacher Foundation, Inc.
  • AstraZeneca Pharmaceuticals LP
  • Biotechnology Industry Organization (BIO)
  • Diplomat Specialty Pharmacy
  • GlycoMimetics, Inc.
  • Kate Obstgarten Family Foundation
  • Lapidus Data
  • Medco Health Solutions
  • Rubin Family Foundation
  • Salix Pharmaceuticals
  • Schechter Foundation
  • Schifter Family Foundation
  • Seaside Therapeutics
  • Trimethylaminuria Foundation

*****************************

Contributions were received during the period of
January 1, 2011 to December 31, 2011.

Code of Conduct for Corporate Supporters

 
Copyright ©2014 NORD - National Organization for Rare Disorders, Inc. All rights reserved.